Sherrington Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Sherrington Pharmaceuticals Ownership

Who owns Sherrington Pharmaceuticals?

Sherrington Pharmaceuticals is owned by Sorrento Therapeutics. It was acquired on October 9, 2013.

Sherrington Pharmaceuticals Business Overview

Where is Sherrington Pharmaceuticals headquartered?

Sherrington Pharmaceuticals is headquartered in New York, New York.

What sector is Sherrington Pharmaceuticals in?

Sherrington Pharmaceuticals is a life science company.

When was Sherrington Pharmaceuticals founded?

Sherrington Pharmaceuticals was founded in 2009.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 192 acquisitions of life science companies in 2013, including 26 acquisitions by private equity firms, and 166 by strategics.

Sherrington Pharmaceuticals, Inc.

1251 Avenue Of The Americas Floor 20,
New York, New York 10020
United States,
(212) 430-1738

Sherrington Pharmaceuticals, Inc. is a bio pharmaceutical company provides chronic and refractory pain treatment for end-stage cancer patients.


 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.